Immunomedics
IMMU
#1179
Rank
$20.30 B
Marketcap
$87.86
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Immunomedics (IMMU)

Revenue in 2020 (TTM): $21.23 Million USD

According to Immunomedics's latest financial reports the company's current revenue is $21.23 Million USD. In 2017 the company made a revenue of $3.25 Million USD an increase over the revenue in the year 2016 that were of $2.95 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immunomedics from 2001 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)$21.23 M
2017$3.25 M10%
2016$2.95 M-40.62%
2015$4.98 M12.78%
2014$4.41 M-54.93%
2013$9.79 M158.04%
2012$3.79 M-91.17%
2011$43.01 M122.79%
2010$19.3 M-68.21%
2009$60.72 M297.36%
2008$15.28 M329.31%
2007$3.55 M-65.09%
2006$10.19 M294.58%
2005$2.58 M-39.59%
2004$4.27 M-55.59%
2003$9.63 M-48.69%
2002$18.76 M73.31%
2001$10.82 M